Mpox | Page 2 | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Explainer
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Friday
January 16, 2026

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Explainer
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
FRIDAY, JANUARY 16, 2026

Mpox

Mpox

A test tube labelled "Mpox virus positive" is held in this illustration taken August 20, 2024. Photo: REUTERS/Dado Ruvic/Illustration/File Photo

Nigeria to start mpox vaccination on October 8

Nigeria received the first batch of 10,000 doses of the mpox vaccine from the US Agency for International Development on Tuesday. The country has confirmed 40 mpox cases with no fatalities yet

A laboratory nurse takes a sample from a child declared a suspected case of Mpox at the treatment centre in Munigi, Democratic Republic of the Congo July 19, 2024. Photo: REUTERS/Arlette Bashizi/File Photo

UNICEF issues emergency tender to secure mpox vaccines

An undated colorized transmission electron micrograph of mpox virus particles (pink) found within an infected cell (yellow), cultured in the laboratory, captured at the National Institute of Allergy and Infectious Diseases (NIAID) Integrated Research Facility (IRF) in Fort Detrick, Maryland. Photo: NIAID/Handout via REUTERS

New mpox strain is changing fast; African scientists are ‘working blindly’ to respond

Internally displaced women listen to Nathalie Kipenzi, a hygiene promoter, during an awareness campaign for Mpox, an infectious disease caused by the monkeypox virus that causes a painful rash, enlarged lymph nodes and fever, at the Muja camp for the internally displaced in Nyiragongo territory, near Goma in North Kivu province of the Democratic Republic of Congo August 19, 2024. Photo: REUTERS/Arlette Bashizi

Why mpox vaccines are only just arriving in Africa after two years

Hazrat Shahjalal International Airport, Dhaka. File Photo

Bangladeshi traveling from Qatar suspected of mpox tests negative

A person holds doses of Bavarian Nordic's Imvanex vaccine, used to protect against mpox virus, at the Edison municipal vaccination centre in Paris, France July 27, 2022. Photo: Alain Jocard/Pool via REUTERS/File Photo

WHO says partners can start talks to buy mpox vaccines before its approval

A test tube labelled "Mpox virus positive" is held in this illustration taken August 20, 2024. Photo: REUTERS/Dado Ruvic/Illustration/File Photo

WHO boss calls for $135 million to stop mpox outbreak

An undated colorized scanning electron micrograph of mpox virus (red) on the surface of infected VERO E6 cells (green), captured at the National Institute of Allergy and Infectious Diseases (NIAID) Integrated Research Facility (IRF) in Fort Detrick, Maryland. Photo: NIAID/Handout via REUTERS

​​​​​​​Countries with confirmed cases of new mpox variant

An undated colorized transmission electron micrograph of mpox virus particles (pink) found within an infected cell (yellow), cultured in the laboratory, captured at the National Institute of Allergy and Infectious Diseases (NIAID) Integrated Research Facility (IRF) in Fort Detrick, Maryland. Photo: NIAID/Handout via REUTERS

Enhanced measures against Mpox at airports and entry points

Internally displaced women listen to Nathalie Kipenzi, a hygiene promoter, during an awareness campaign for Mpox, an infectious disease caused by the monkeypox virus that causes a painful rash, enlarged lymph nodes and fever, at the Muja camp for the internally displaced in Nyiragongo territory, near Goma in North Kivu province of the Democratic Republic of Congo August 19, 2024. Photo: REUTERS/Arlette Bashizi

Mpox surge in Central Africa exposes the most vulnerable

A drone view shows ships used to carry grains for export on the Parana River, in Rosario, Argentina August 9, 2024. Photo: REUTERS/Matias Baglietto/File Photo

Argentina quarantines grains ship over suspected mpox case

A test tube labelled "Mpox virus positive" is held in this illustration taken August 20, 2024. Photo: REUTERS/Dado Ruvic/Illustration/File Photo

Philippines says recent mpox case is mild Clade 2 variant

An undated colorized scanning electron micrograph of mpox virus (red) on the surface of infected VERO E6 cells (green), captured at the National Institute of Allergy and Infectious Diseases (NIAID) Integrated Research Facility (IRF) in Fort Detrick, Maryland. Photo: NIAID/Handout via REUTERS

Mpox is not the new COVID: WHO official

  • Show More
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2026
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net